N-[4-Ferrocenyl-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazol-2-yl]-2-nitrobenzamide
✍ Scribed by Shao, Ling ;Zhou, Xin ;Hu, Yan ;Fang, Jian-Xin
- Publisher
- International Union of Crystallography
- Year
- 2005
- Tongue
- English
- Weight
- 397 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
The title compound, [Fe(C 5 H 5 )(C 17 H 11 N 6 O 3 S)], has been synthesized as a potential anticancer agent. There are two molecules in the asymmetric unit. In the crystal structure, the molecules are associated via N-HÁ Á ÁN and C-HÁ Á ÁO interactions.
📜 SIMILAR VOLUMES
The title compound, C 17 H 12 ClN 5 S, has been synthesized as a potent anticancer agent. The dihedral angle between the thiazole and triazole rings is 85.9 (2) . There are intermolecular N-HÁ Á ÁN and C-HÁ Á ÁCl interactions in the crystal structure.
In the title compound, C 16 H 13 Cl 3 N 6 O 3 S, the substituted triazole ring is bound via a methylene bridge to a chlorothiazole unit. There is evidence for significant electron delocalization in the triazolyl system. Both intra-and intermolecular hydrogen bonds are found in the structure.